Editorial: Cost-effectiveness of genotyping in inherited arrhythmia syndromes are we getting value for themoney?

Circulation: Arrhythmia and Electrophysiology

Volumn 2, Issue 1, 2009, Pages 1-3

  Wilde, Arthur A M ^a   Pinto, Yigal M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Arrhythmia; Cost benefit analysis; Genetics; Heart arrest; Long QT syndrome

Indexed keywords

BRUGADA SYNDROME; CARDIAC CHANNELOPATHY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; EDITORIAL; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; INHERITED ARRHYTHMIA SYNDROME; LONG QT SYNDROME; MISSENSE MUTATION; MOLECULAR GENETICS; PHENOTYPE; PRIORITY JOURNAL; SHORT QT SYNDROME; SUDDEN DEATH; ATRIOVENTRICULAR BLOCK; COST BENEFIT ANALYSIS; ECONOMICS; GENETIC PREDISPOSITION; GENETICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEART VENTRICLE TACHYCARDIA; MASS SCREENING; METHODOLOGY; NOTE; PATIENT SELECTION; PREDICTION AND FORECASTING; REIMBURSEMENT;

ION CHANNEL;

ARRHYTHMIAS, CARDIAC; ATRIOVENTRICULAR BLOCK; BRUGADA SYNDROME; COST-BENEFIT ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEALTH CARE COSTS; HEALTH PRIORITIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; ION CHANNELS; LONG QT SYNDROME; MASS SCREENING; PATIENT SELECTION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; TACHYCARDIA, VENTRICULAR;

EID: 70349335566     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.109.849000     Document Type: Editorial

References (12)

1. Moss AJ, Goldenberg I. Importance of knowing the genotype and the specific mutation when managing patients with long-QT syndrome. Circ Arrhythmia Electrophysiol. 2008; 117:219-226.
2. Bai R, Napolitano C, Bloise R, Monteforte N, Priori SG. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic screening. Circ Arrhythmia Electrophysiol. 2009; 2:6-15.
3. Hendriks KSWH, Grosfeld FJM, Wilde AAM, van den Bout J, van Langen IM, van Tintelen JP, ten Kroode HFJ. High distress in parents whose children undergo predictive genetic testing for long QT syndrome. Community Genetics. 2005; 8:103-113. Hendriks KSWH, Hendriks MMWB, Birnie E, Grosfeld FJM, Wilde AAM, van den Bout J, Smets EMA, van Tintelen JP, ten Kroode HFJ, van Langen IM. Familial disease with a risk on sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Heart Rhythm. 2008;5:719 -724.
4. Taggart NW, Haglund CM, Tester DJ, Ackerman MJ. Diagnostic miscues in congenital long-QT syndrome. Circulation. 2007; 115:2613-2620.
5. Smits JPP, Eckardt L, Probst V, Bezzina CR, Schott JJ, Remme CA, Haverkamp W, Breithardt G, Escande D, schulze-Bahr E, le Marec H, Wilde AAM. Genotype-phenotype relationship in Brugada syndrome; electrocardiographic features differentiate SCN5A-related patients from non-SCN5A related patients. J Am Coll Cardiol. 2002; 40:350-356.
6. van Langen IM, Birnie E, Alders M, Jongbloed RJ, Le Marec H, Wilde AAM. The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. J Med Gen. 2003; 40:141-145.
7. Moss AJ, Shimizu W, Wilde AAM, Towbin JA, Zareba W, Robinson JL, Lopes CMB, Qi M, Vincent M, Ackerman MJ, Kaufman E, Hofman N, Seth R, Kamakura S, Miyamoto Y, Goldenberg I, Andrews ML, McNitt S. Clinical aspects of type-1 long-QT Syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007; 115:2481-2489.
8. Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AAM. Sudden unexplained death: heritability, diagnostic yield, and therapeutic yield of cardiologic and genetic examination in surviving relatives. Circulation. 2005; 112:207-213.
9. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Esteban MT, Rowland E, Jeffery S, McKenna WJ. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J. 2008; 29:1670-1680.
10. Fokstuen S, Lyle R, Munoz A, Gehrig C, Lerch R, Perrot A, Osterziel KJ, Geier C, Beghetti M, Mach F, Sztajzel J, Stigwart U, Antonarakis SE, Blouin J. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy. Human Mutation. 2008; 29:879-885.
11. Ackerman MJ, Tester DJ, Jones GS, Will ML, Burrow CR, Curran ME. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc. 2003; 78:1479-1487.
12. Ackerman MJ, Splawski I, Makielski J, Tester D, Will M, Timothy K, Keating M, Jones G, Chadha M, Burrow C. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: Implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm. 2004; 1:600-607.